Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: infliximab | Statement: [Inflectra, isBiosimilarTo, infliximab]

Target entity: infliximab
Context triple: [Inflectra, isBiosimilarTo, infliximab]

• A. Remicade chosen
  Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
• B. Humira
  Humira is a widely used biologic medication (adalimumab) that treats various autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease by inhibiting tumor necrosis factor (TNF).
• C. Stelara
  Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
• D. Kevzara
  Kevzara is a prescription monoclonal antibody medication (sarilumab) used to treat adults with moderate to severe rheumatoid arthritis by targeting the interleukin-6 (IL-6) receptor.
• E. Taltz
  Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: isBiosimilarTo
Context triple: [Inflectra, isBiosimilarTo, infliximab]

• A. hasBiosimilar chosen
  Indicates that one biological product is a biosimilar counterpart to another reference biological product.
• B. isAlternativeTo
  Indicates that one entity can serve as a substitute or different option in place of another.
• C. isProdrugOf
  Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
• D. homologousTo
  Indicates that two entities share a common evolutionary origin or structural similarity, often implying they derive from the same ancestral feature.
• E. isExtendedReleaseFormulationOf
  Indicates that one pharmaceutical formulation is an extended-release version of another, designed to release the active ingredient more slowly over time.
• F. None of above.